Bone mineral density in young adults with Prader‐Willi syndrome: A randomized, placebo‐controlled, crossover GH trial

Summary Context The prevalence of osteoporosis is increased in adults with Prader‐Willi syndrome (PWS). In children with PWS, growth hormone (GH) treatment has beneficial effects on bone mineral density (BMD). BMD might deteriorate after cessation of GH at adult height (AH), while continuing GH migh...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical endocrinology (Oxford) Vol. 88; no. 6; pp. 806 - 812
Main Authors:	Donze, Stephany H., Kuppens, Renske J., Bakker, Nienke E., van Alfen‐van der Velden, Janiëlle A.E.M., Hokken‐Koelega, Anita C.S.
Format:	Journal Article
Language:	English
Published:	England Wiley Subscription Services, Inc 01.06.2018
Subjects:	adult height Body height Bone density Bone mineral density Children growth hormone treatment Growth hormones Hormone replacement therapy Osteoporosis Prader-Willi syndrome sex steroid replacement therapy Spine (lumbar) Young adults adult height sex steroid replacement therapy bone mineral density growth hormone treatment Prader-Willi syndrome young adults
ISSN:	0300-0664, 1365-2265, 1365-2265
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!